Nasopharyngeal carcinoma
Conditions
Interventions
experimental group :radiotherapy
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
All
Age
70 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients who sign informed consent and are willing to complete the study according to the protocol; 2. Patients older than or equal to 70 years old; 3. Patients with ECoG score of 0-2; 4. Patients with newly diagnosed nasopharyngeal carcinoma confirmed by histology; 5. Patients without distant metastasis; 6. Patients without other malignant tumors; 7. The subjects with normal main organ functions shall meet the following requirements: The blood routine test met the following criteria: (1) HB >= 90g/L (2) ANC >=1.5 x 10^9/L (3) PLT >= 80 x 10^9/L Biochemical examination met the following standards: (1) Bil = 50ml / min (Cockcroft Gault formula).
Exclusion criteria
Exclusion criteria: 1. The patient has any psychological, family, social or geographical conditions that may prevent compliance with the study protocol requirements or follow-up procedures; these conditions should be discussed with the patient before entering the study 2. Patients who are not suitable to be included in the evaluation of relevant physicians; 3. Patients with immunodeficiency and HIV infection; 4. Severe liver and kidney insufficiency; 5. Patients who have received radiotherapy in the head and neck.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| acute adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| 3-year Overal survival; | — |
Countries
China
Contacts
Public ContactHongmei Ying
Fudan University Shanghai Cancer Center
Outcome results
None listed